Source: USA Today Valeant Pharmaceuticals International, the Canadian drugmaker whose CEO has been on medical leave while it faces congressional scrutiny over its pricing practices, said Wednesday it appointed Howard B. Schiller as interim CEO, effective immediately. Schiller, who joined Valeant as COO in 2009 after a 24-year career at…...